The competitive advantage stems, according to the complainant, from the fact that the IFP/Axens entity does not have to cover all of its R & D costs and that it can, in consequence, exert downward pressure on market prices in the fields concerned. The complainant considers that such an advantage introduces the risk of a foreclosure effect to the detriment of other market operators.
73 5. COMMENTS FROM THIRD PARTIES › 5.1. Content of the complaint behind the initiation of the procedure, Decision_act (EU) 2009/157
In forcesince 16 Jul 2008